{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:44:20Z","timestamp":1786985060725,"version":"build-2736575974"},"reference-count":71,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.bbrc.2025.153101","type":"journal-article","created":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T00:03:59Z","timestamp":1764979439000},"page":"153101","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Integrating biochemical and computational approaches to identify targeted therapeutic strategies for liver fibrosis: Effects of Telaglenastat (CB-839) on the glutaminase pathway"],"prefix":"10.1016","volume":"795","author":[{"given":"Hoda E.","family":"Fakher","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eman T.","family":"Mehanna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdel-Aziz A.","family":"Zidan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8863-968X","authenticated-orcid":false,"given":"Noha M.","family":"Mesbah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dina M.","family":"Abo-Elmatty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sherin R.","family":"El-Afify","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghada M.","family":"Al-Ashmawy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.bbrc.2025.153101_bib1","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jhep.2018.09.014","article-title":"Burden of liver diseases in the world","volume":"70","author":"Asrani","year":"2019","journal-title":"J. Hepatol."},{"issue":"9","key":"10.1016\/j.bbrc.2025.153101_bib2","article-title":"Non-alcoholic fatty liver disease and diabetes mellitus as growing aetiologies of hepatocellular carcinoma","volume":"5","author":"Talamantes","year":"2023","journal-title":"JHEP Rep."},{"issue":"17","key":"10.1016\/j.bbrc.2025.153101_bib3","doi-asserted-by":"crossref","DOI":"10.3390\/cells12172129","article-title":"Liver injury and regeneration: current understanding, new approaches, and future perspectives","volume":"12","author":"Hora","year":"2023","journal-title":"Cells"},{"issue":"7","key":"10.1016\/j.bbrc.2025.153101_bib4","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1038\/nm.2807","article-title":"Mechanisms of fibrosis: therapeutic translation for fibrotic disease","volume":"18","author":"Wynn","year":"2012","journal-title":"Nat. Med."},{"issue":"3","key":"10.1016\/j.bbrc.2025.153101_bib5","doi-asserted-by":"crossref","first-page":"133","DOI":"10.15171\/mejdd.2018.103","article-title":"New concepts on reversibility and targeting of liver fibrosis; A review article","volume":"10","author":"Ebrahimi","year":"2018","journal-title":"Middle East J. Dig. Dis."},{"issue":"8","key":"10.1016\/j.bbrc.2025.153101_bib6","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1113\/JP281061","article-title":"Hepatic stellate cells in physiology and pathology","volume":"600","author":"Kamm","year":"2022","journal-title":"J. Physiol."},{"issue":"3","key":"10.1016\/j.bbrc.2025.153101_bib7","doi-asserted-by":"crossref","first-page":"615","DOI":"10.47162\/RJME.61.3.01","article-title":"Hepatic stellate cells - from past till present: morphology, human markers, human cell lines, behavior in normal and liver pathology","volume":"61","author":"Sufle\u0163el","year":"2020","journal-title":"Romanian Journal Morphol. Embryol. = Revue roumaine de morphologie et embryologie"},{"issue":"11","key":"10.1016\/j.bbrc.2025.153101_bib8","doi-asserted-by":"crossref","DOI":"10.3390\/nu10111564","article-title":"Glutamine: metabolism and immune function, supplementation and clinical translation","volume":"10","author":"Cruzat","year":"2018","journal-title":"Nutrients"},{"issue":"10","key":"10.1016\/j.bbrc.2025.153101_bib9","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1038\/nrc.2016.71","article-title":"From Krebs to clinic: glutamine metabolism to cancer therapy","volume":"16","author":"Altman","year":"2016","journal-title":"Nat. Rev. Cancer"},{"issue":"21","key":"10.1016\/j.bbrc.2025.153101_bib10","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222111763","article-title":"P5C as an interface of proline interconvertible amino acids and its role in regulation of cell survival and apoptosis","volume":"22","author":"Chalecka","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.bbrc.2025.153101_bib11","doi-asserted-by":"crossref","first-page":"223","DOI":"10.4155\/fmc-2016-0190","article-title":"A tale of two glutaminases: homologous enzymes with distinct roles in tumorigenesis","volume":"9","author":"Katt","year":"2017","journal-title":"Future Med. Chem."},{"issue":"1","key":"10.1016\/j.bbrc.2025.153101_bib12","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.celrep.2019.08.076","article-title":"Liver-type glutaminase GLS2 is a druggable metabolic node in luminal-subtype breast cancer","volume":"29","author":"Lukey","year":"2019","journal-title":"Cell Rep."},{"issue":"12","key":"10.1016\/j.bbrc.2025.153101_bib13","doi-asserted-by":"crossref","DOI":"10.3390\/cells10123604","article-title":"Metabolic reprogramming of liver fibrosis","volume":"10","author":"Delgado","year":"2021","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.bbrc.2025.153101_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jcmgh.2019.12.006","article-title":"Increased glutaminolysis marks active scarring in nonalcoholic steatohepatitis progression","volume":"10","author":"Du","year":"2020","journal-title":"Cellular and molecular gastroenterology and hepatology"},{"key":"10.1016\/j.bbrc.2025.153101_bib15","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.bbi.2020.11.038","article-title":"Glutaminase in microglia: a novel regulator of neuroinflammation","volume":"92","author":"Ding","year":"2021","journal-title":"Brain Behav. Immun."},{"issue":"8","key":"10.1016\/j.bbrc.2025.153101_bib16","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/j.trecan.2021.04.003","article-title":"Enhancing the efficacy of Glutamine metabolism inhibitors in cancer therapy","volume":"7","author":"Yang","year":"2021","journal-title":"Trends Cancer"},{"issue":"3","key":"10.1016\/j.bbrc.2025.153101_bib17","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1158\/1535-7163.MCT-20-0430","article-title":"The glutaminase inhibitor CB-839 (Telaglenastat) enhances the Antimelanoma activity of T-Cell-Mediated immunotherapies","volume":"20","author":"Varghese","year":"2021","journal-title":"Mol. Cancer Therapeut."},{"key":"10.1016\/j.bbrc.2025.153101_bib18","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2018.00709","article-title":"Palmitoylethanolamide ameliorates carbon tetrachloride-induced liver fibrosis in rats","volume":"9","author":"Ohara","year":"2018","journal-title":"Front. Pharmacol."},{"issue":"4","key":"10.1016\/j.bbrc.2025.153101_bib19","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1080\/09553002.2018.1558299","article-title":"Glutaminase inhibitor CB-839 increases radiation sensitivity of lung tumor cells and human lung tumor xenografts in mice","volume":"95","author":"Boysen","year":"2019","journal-title":"Int. J. Radiat. Biol."},{"issue":"2","key":"10.1016\/j.bbrc.2025.153101_bib20","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics13020295","article-title":"Augmented therapeutic potential of glutaminase inhibitor CB839 in glioblastoma stem cells using gold nanoparticle delivery","volume":"13","author":"Giesen","year":"2021","journal-title":"Pharmaceutics"},{"issue":"3","key":"10.1016\/j.bbrc.2025.153101_bib21","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.celrep.2016.12.061","article-title":"Targeted inhibition of EGFR and glutaminase induces metabolic crisis in EGFR mutant lung cancer","volume":"18","author":"Momcilovic","year":"2017","journal-title":"Cell Rep."},{"issue":"7","key":"10.1016\/j.bbrc.2025.153101_bib22","doi-asserted-by":"crossref","first-page":"8920","DOI":"10.1096\/fj.202000564R","article-title":"SIRT7-mediated modulation of glutaminase 1 regulates TGF-\u03b2-induced pulmonary fibrosis","volume":"34","author":"Choudhury","year":"2020","journal-title":"FASEB J."},{"key":"10.1016\/j.bbrc.2025.153101_bib23","article-title":"The glutaminase inhibitor compound 968 exhibits potent in vitro and in vivo anti-tumor effects in endometrial cancer","author":"Guo","year":"2022","journal-title":"Anti Cancer Agents Med. Chem."},{"issue":"2","key":"10.1016\/j.bbrc.2025.153101_bib24","first-page":"1","article-title":"N-Acetyl cysteine alleviates carbon-tetrachloride induced acute liver injury in rats","volume":"2","author":"Mansour","year":"2022","journal-title":"NVVJ"},{"key":"10.1016\/j.bbrc.2025.153101_bib25","series-title":"F0D8 can the Liver Regenerative Potential Restore the Normal Liver Structure in Mice CCL4 Induced Liver Fibrosis? A Histological and Immunohistochemical Study","author":"Saad El-dien","year":"2018"},{"issue":"2","key":"10.1016\/j.bbrc.2025.153101_bib26","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1002\/ame2.12198","article-title":"Anesthesia protocol for ear surgery in Wistar rats (animal research)","volume":"5","author":"Bhatia","year":"2022","journal-title":"Animal Models Experimental Med."},{"issue":"3","key":"10.1016\/j.bbrc.2025.153101_bib27","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aba1028","article-title":"Ionizable lipid nanoparticles for in utero mRNA delivery","volume":"7","author":"Riley","year":"2021","journal-title":"Sci. Adv."},{"issue":"1","key":"10.1016\/j.bbrc.2025.153101_bib28","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1002\/2211-5463.13338","article-title":"5-Aminolevulinic acid and sodium ferrous citrate ameliorate muscle aging and extend healthspan in Drosophila","volume":"12","author":"Nozawa","year":"2022","journal-title":"FEBS Open Bio."},{"key":"10.1016\/j.bbrc.2025.153101_bib29","series-title":"International Conference on Advanced Materials and Systems (ICAMS)","doi-asserted-by":"crossref","first-page":"105","DOI":"10.24264\/icams-2016.I.15","article-title":"Medical bioproducts collagen quantification by hydroxyproline determination","author":"Macovescu","year":"2016"},{"issue":"9","key":"10.1016\/j.bbrc.2025.153101_bib30","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0076581","article-title":"STAT1 regulates human glutaminase 1 promoter activity through multiple binding sites in HIV-1 infected macrophages","volume":"8","author":"Zhao","year":"2013","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.bbrc.2025.153101_bib31","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1053\/j.gastro.2017.12.022","article-title":"Hedgehog-YAP signaling pathway regulates glutaminolysis to control activation of hepatic stellate cells","volume":"154","author":"Du","year":"2018","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.bbrc.2025.153101_bib32","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s12896-016-0256-y","article-title":"A simple, accurate and universal method for quantification of PCR","volume":"16","author":"Boulter","year":"2016","journal-title":"BMC Biotechnol."},{"issue":"2","key":"10.1016\/j.bbrc.2025.153101_bib33","doi-asserted-by":"crossref","first-page":"169","DOI":"10.2174\/1568009622666211224111425","article-title":"The expression of glutaminases and their association with clinicopathological parameters in the head and neck cancers","volume":"22","author":"Basheer","year":"2022","journal-title":"Curr. Cancer Drug Targets"},{"key":"10.1016\/j.bbrc.2025.153101_bib34","article-title":"A comprehensive analysis and validation of cuproptosis-associated genes across cancers: overall survival, the tumor microenvironment, stemness scores, and drug sensitivity","volume":"13","author":"Liu","year":"2022","journal-title":"Front. Genet."},{"issue":"1","key":"10.1016\/j.bbrc.2025.153101_bib35","doi-asserted-by":"crossref","first-page":"2","DOI":"10.3390\/biom10010002","article-title":"High levels of glutaminase II pathway enzymes in normal and cancerous prostate suggest a role in \u2018Glutamine Addiction\u2019","volume":"10","author":"Dorai","year":"2020","journal-title":"Biomolecules"},{"issue":"16","key":"10.1016\/j.bbrc.2025.153101_bib36","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13163963","article-title":"The biological and clinical significance of glutaminase in luminal breast cancer","volume":"13","author":"Masisi","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"3","key":"10.1016\/j.bbrc.2025.153101_bib37","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1002\/cbf.1215","article-title":"Histological changes in the liver of fetuses of alcohol-treated pregnant rats","volume":"24","author":"Ko\u00e7kaya","year":"2006","journal-title":"Cell Biochem. Funct."},{"issue":"2","key":"10.1016\/j.bbrc.2025.153101_bib38","doi-asserted-by":"crossref","first-page":"447","DOI":"10.3390\/app10020447","article-title":"Quantification of liver fibrosis\u2014A comparative study","volume":"10","author":"Arjmand","year":"2020","journal-title":"Appl. Sci."},{"key":"10.1016\/j.bbrc.2025.153101_bib39","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2020.570065","article-title":"Assessment of depression severity during coronavirus disease 2019 pandemic among the Palestinian population: a growing concern and an immediate consideration","volume":"11","author":"Al Zabadi","year":"2020","journal-title":"Front. Psychiatr."},{"issue":"5","key":"10.1016\/j.bbrc.2025.153101_bib40","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1093\/jn\/nxaa032","article-title":"One-carbon metabolism in fatty liver disease and fibrosis: one-carbon to rule them all","volume":"150","author":"Robin","year":"2020","journal-title":"J. Nutr."},{"issue":"10","key":"10.1016\/j.bbrc.2025.153101_bib41","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1016\/j.bbadis.2013.06.001","article-title":"Overexpression of c-myc in hepatocytes promotes activation of hepatic stellate cells and facilitates the onset of liver fibrosis","volume":"1832","author":"Nevzorova","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbrc.2025.153101_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.aohep.2020.06.010","article-title":"STAT3: a key regulator in liver fibrosis","volume":"21","author":"Zhao","year":"2021","journal-title":"Ann. Hepatol."},{"issue":"4","key":"10.1016\/j.bbrc.2025.153101_bib43","doi-asserted-by":"crossref","first-page":"302","DOI":"10.3350\/cmh.2017.0078","article-title":"Histopathological evaluation of liver fibrosis and cirrhosis regression","volume":"23","author":"Lo","year":"2017","journal-title":"Clin. Mol. Hepatol."},{"issue":"1","key":"10.1016\/j.bbrc.2025.153101_bib44","doi-asserted-by":"crossref","DOI":"10.3390\/mps5010013","article-title":"A one-stop protocol to assess myocardial fibrosis in frozen and paraffin sections","volume":"5","author":"Sridharan","year":"2022","journal-title":"Methods Protoc."},{"issue":"10","key":"10.1016\/j.bbrc.2025.153101_bib45","doi-asserted-by":"crossref","DOI":"10.21769\/BioProtoc.3629","article-title":"Analysis of generalized fibrosis in mouse tissue sections with Masson's trichrome staining","volume":"10","author":"Van De Vlekkert","year":"2020","journal-title":"Bio-protocol"},{"issue":"3","key":"10.1016\/j.bbrc.2025.153101_bib46","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/j.jhep.2020.09.037","article-title":"Hepatocyte-specific NRF2 activation controls fibrogenesis and carcinogenesis in steatohepatitis","volume":"74","author":"Mohs","year":"2021","journal-title":"J. Hepatol."},{"issue":"9","key":"10.1016\/j.bbrc.2025.153101_bib47","doi-asserted-by":"crossref","DOI":"10.3390\/antiox12091653","article-title":"Oxidative stress in liver pathophysiology and disease","volume":"12","author":"Allameh","year":"2023","journal-title":"Antioxidants"},{"key":"10.1016\/j.bbrc.2025.153101_bib48","doi-asserted-by":"crossref","first-page":"9","DOI":"10.21037\/tgh.2020.02.21","article-title":"Fibrosis and hepatic regeneration mechanism","volume":"7","author":"Zu\u00f1iga-Aguilar","year":"2022","journal-title":"Transl. Gastroenterol. Hepatol."},{"issue":"1","key":"10.1016\/j.bbrc.2025.153101_bib49","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/ajg.2016.517","article-title":"ACG clinical guideline: evaluation of abnormal liver chemistries","volume":"112","author":"Kwo","year":"2017","journal-title":"Am. J. Gastroenterol."},{"issue":"6","key":"10.1016\/j.bbrc.2025.153101_bib50","doi-asserted-by":"crossref","first-page":"596","DOI":"10.2174\/1389203717666151201192247","article-title":"Hydroxyproline: a potential biochemical marker and its role in the pathogenesis of different diseases","volume":"17","author":"Srivastava","year":"2016","journal-title":"Curr. Protein Pept. Sci."},{"issue":"1","key":"10.1016\/j.bbrc.2025.153101_bib51","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s13058-019-1141-0","article-title":"Glutamine to proline conversion is associated with response to glutaminase inhibition in breast cancer","volume":"21","author":"Grinde","year":"2019","journal-title":"Breast Cancer Res."},{"issue":"2","key":"10.1016\/j.bbrc.2025.153101_bib52","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1038\/s41416-020-01113-y","article-title":"Increased expression of glutamine transporter SNAT2\/SLC38A2 promotes glutamine dependence and oxidative stress resistance, and is associated with worse prognosis in triple-negative breast cancer","volume":"124","author":"Morotti","year":"2021","journal-title":"Br. J. Cancer"},{"issue":"11","key":"10.1016\/j.bbrc.2025.153101_bib53","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20112767","article-title":"TGF-\u03b2-Mediated epithelial-mesenchymal transition and cancer metastasis","volume":"20","author":"Hao","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"9","key":"10.1016\/j.bbrc.2025.153101_bib54","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.1182\/bloodadvances.2023010950","article-title":"The glutaminase inhibitor CB-839 targets metabolic dependencies of JAK2-mutant hematopoiesis in MPN","volume":"8","author":"Usart","year":"2024","journal-title":"Blood Adv."},{"issue":"2","key":"10.1016\/j.bbrc.2025.153101_bib55","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s00018-012-1046-x","article-title":"Peroxisome proliferator-activated receptor-\u03b3 as a therapeutic target for hepatic fibrosis: from bench to bedside","volume":"70","author":"Zhang","year":"2013","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.bbrc.2025.153101_bib56","article-title":"Bergenin attenuates hepatic fibrosis by regulating autophagy mediated by the PPAR-\u03b3\/TGF-\u03b2 pathway","volume":"2012","author":"Xia","year":"2020","journal-title":"PPAR Res."},{"issue":"24","key":"10.1016\/j.bbrc.2025.153101_bib57","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21249739","article-title":"The roles of matrix metalloproteinases and their inhibitors in human diseases","volume":"21","author":"Cabral-Pacheco","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.bbrc.2025.153101_bib58","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.celrep.2016.12.061","article-title":"Targeted inhibition of EGFR and glutaminase induces metabolic crisis in EGFR mutant lung cancer","volume":"18","author":"Momcilovic","year":"2017","journal-title":"Cell Rep."},{"issue":"1","key":"10.1016\/j.bbrc.2025.153101_bib59","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1183\/09031936.00146510","article-title":"Biological role of matrix metalloproteinases: a critical balance","volume":"38","author":"L\u00f6ffek","year":"2010","journal-title":"Eur. Respir. J."},{"issue":"1","key":"10.1016\/j.bbrc.2025.153101_bib60","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/1106313","article-title":"Pharmacological inhibition of glutaminase 1 attenuates alkali-induced corneal neovascularization by modulating macrophages","volume":"2022","author":"Feng","year":"2022","journal-title":"Oxid. Med. Cell. Longev."},{"issue":"1","key":"10.1016\/j.bbrc.2025.153101_bib61","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/2045-3701-1-14","article-title":"Tissue inhibitor of metalloproteinase 1 (TIMP-1) deficiency exacerbates carbon tetrachloride-induced liver injury and fibrosis in mice: involvement of hepatocyte STAT3 in TIMP-1 production","volume":"1","author":"Wang","year":"2011","journal-title":"Cell Biosci."},{"issue":"19","key":"10.1016\/j.bbrc.2025.153101_bib62","doi-asserted-by":"crossref","first-page":"3044","DOI":"10.3748\/wjg.v12.i19.3044","article-title":"Correlation between TIMP-1 expression and liver fibrosis in two rat liver fibrosis models","volume":"12","author":"Nie","year":"2006","journal-title":"World J. Gastroenterol."},{"issue":"2","key":"10.1016\/j.bbrc.2025.153101_bib63","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.jss.2009.10.038","article-title":"Differential expression of hepatic fibrosis mediators in sick and spontaneously recovered mice with experimental biliary atresia","volume":"159","author":"Nadler","year":"2010","journal-title":"J. Surg. Res."},{"issue":"3","key":"10.1016\/j.bbrc.2025.153101_bib64","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/S1386-6346(01)00134-6","article-title":"High serum glyceraldehyde-3-phosphate dehydrogenase levels in patients with liver cirrhosis","volume":"22","author":"Shibuya","year":"2002","journal-title":"Hepatol. Res. : Off. J. Japan Soc. Hepatol."},{"key":"10.1016\/j.bbrc.2025.153101_bib65","doi-asserted-by":"crossref","DOI":"10.1016\/j.aohep.2020.06.010","article-title":"STAT3: a key regulator in liver fibrosis","volume":"21","author":"Zhao","year":"2021","journal-title":"Ann. Hepatol."},{"key":"10.1016\/j.bbrc.2025.153101_bib66","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2021.119460","article-title":"Chlorogenic acid, quercetin, coenzyme Q10 and silymarin modulate Keap1-Nrf2\/heme oxygenase-1 signaling in thioacetamide-induced acute liver toxicity","volume":"277","author":"Hussein","year":"2021","journal-title":"Life Sci."},{"issue":"2","key":"10.1016\/j.bbrc.2025.153101_bib67","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1177\/1535370219898141","article-title":"Mechanisms of liver fibrosis and its role in liver cancer","volume":"245","author":"Dhar","year":"2020","journal-title":"Exp. Biol. Med."},{"key":"10.1016\/j.bbrc.2025.153101_bib68","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2024.1389329","article-title":"The role of PI3k\/AKT signaling pathway in attenuating liver fibrosis: a comprehensive review","volume":"11","author":"Shamsan","year":"2024","journal-title":"Front. Med."},{"issue":"29","key":"10.1016\/j.bbrc.2025.153101_bib69","doi-asserted-by":"crossref","first-page":"6652","DOI":"10.3748\/wjg.v22.i29.6652","article-title":"MicroRNAs in liver fibrosis: focusing on the interaction with hedgehog signaling","volume":"22","author":"Hyun","year":"2016","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.bbrc.2025.153101_bib70","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.5858\/2007-131-1728-HSCALF","article-title":"Hepatic stellate cells and liver fibrosis","volume":"131","author":"Moreira","year":"2007","journal-title":"Arch. Pathol. Lab Med."},{"issue":"1","key":"10.1016\/j.bbrc.2025.153101_bib71","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/path.4829","article-title":"Animal models of non-alcoholic fatty liver disease: current perspectives and recent advances","volume":"241","author":"Lau","year":"2017","journal-title":"J. Pathol."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X25018170?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X25018170?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T04:04:34Z","timestamp":1781323474000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X25018170"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":71,"alternative-id":["S0006291X25018170"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2025.153101","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Integrating biochemical and computational approaches to identify targeted therapeutic strategies for liver fibrosis: Effects of Telaglenastat (CB-839) on the glutaminase pathway","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2025.153101","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"153101"}}